Nkarta (NKTX) Cash & Equivalents (2019 - 2026)

Nkarta (NKTX) recorded quarterly Cash & Equivalents of $266.7 million in Q1 2026, up 572.91% quarter-over-quarter from $39.6 million in Q4 2025, and up 407.05% on a YoY basis from $52.6 million in Q1 2025.

Nkarta (NKTX) Cash & Equivalents (2019 - 2026) Analysis & Trends

Nkarta's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $266.7 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 407.05% year-over-year to $266.7 million; the TTM figure through Mar 2026 stood at $266.7 million (up 407.05% YoY), while the FY2025 annual figure was $39.6 million, up 42.19% from the prior year.
  • Cash & Equivalents was $266.7 million for Q1 2026 at Nkarta, up from $39.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $334.0 million in Q2 2025 to a low of $27.9 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $94.8 million across 5 years, with a median of $52.6 million in 2025.
  • The sharpest annual moves came in 2022 and 2025: Cash & Equivalents jumped 439.07% in 2022, then tumbled 78.98% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $37.5 million in 2022, then slipped by 17.21% to $31.0 million in 2023, then fell by 10.2% to $27.9 million in 2024, then jumped by 42.19% to $39.6 million in 2025, then surged by 572.91% to $266.7 million in 2026.
  • The last three Cash & Equivalents figures came in at $266.7 million (Q1 2026), $39.6 million (Q4 2025), and $60.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 32.30 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 1.91 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 2.77 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 18.44 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 5.49 Bn
9 Abivax 90.15 Bn 90.15 Bn - 558.94 Mn
10 Nkarta 210.15 Mn 210.15 Mn - 266.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 266.70 Mn
Dec 31, 2025 39.63 Mn
Sep 30, 2025 60.11 Mn
Jun 30, 2025 334.00 Mn
Mar 31, 2025 52.60 Mn
Dec 31, 2024 27.87 Mn
Sep 30, 2024 56.96 Mn
Jun 30, 2024 120.40 Mn
Mar 31, 2024 250.29 Mn
Dec 31, 2023 31.04 Mn
Sep 30, 2023 38.26 Mn
Jun 30, 2023 29.12 Mn
Mar 31, 2023 53.67 Mn
Dec 31, 2022 37.49 Mn
Sep 30, 2022 39.65 Mn
Jun 30, 2022 131.65 Mn
Mar 31, 2022 41.61 Mn
Dec 31, 2021 60.82 Mn
Sep 30, 2021 96.22 Mn
Jun 30, 2021 24.42 Mn